NOVONIX Ltd Files September 2024 Form 6-K

Ticker: NVNXF · Form: 6-K · Filed: Sep 4, 2024 · CIK: 1859795

Sentiment: neutral

Topics: sec-filing, 6-K, routine-report

TL;DR

NOVONIX filed its monthly 6-K, standard procedure, nothing major flagged.

AI Summary

NOVONIX Limited filed a Form 6-K on September 4, 2024, reporting its activities for the month of September 2024. The filing includes Appendix 2A, which is a standard exhibit for reporting purposes. NOVONIX is incorporated in Australia and its fiscal year ends on December 31.

Why It Matters

This filing provides routine updates and disclosures for NOVONIX Limited, a company involved in the electrical machinery sector, which is important for investors tracking its compliance and reporting.

Risk Assessment

Risk Level: low — The filing is a routine report (6-K) and does not appear to contain any significant new risks or negative information.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the company makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.

What is included in this specific Form 6-K filing?

This Form 6-K includes Exhibit 99.1, which is described as Appendix 2A.

When is NOVONIX Limited's fiscal year end?

NOVONIX Limited's fiscal year ends on December 31.

Where is NOVONIX Limited's principal executive office located?

NOVONIX Limited's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.

Does NOVONIX Limited file its annual reports under Form 20-F or 40-F?

NOVONIX Limited indicates that it files its annual reports under cover of Form 20-F.

Filing Stats: 209 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2024-09-04 17:23:32

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: September 4, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing